ABCL - AbCellera Biologics' (ABCL) CEO Carl Hansen on Q4 2020 Results - Earnings Call Transcript
AbCellera Biologics, Inc. (ABCL) Q4 2020 Earnings Conference Call March 29, 2021 5:00 PM ET Company Participants Tryn Stimart – Chief Legal Officer, Chief Compliance Officer and Corporate Secretary Carl Hansen – President and Chief Executive Officer Andrew Booth – Chief Financial Officer Conference Call Participants Tiago Fauth – Credit Suisse Stephen Willey – Stifel Gal Munda – Berenberg Puneet Souda – SVB Leerink Do Kim – BMO Presentation Operator Good day and thank you for standing by. Welcome to the AbCellera 2020 Business Update Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to Tryn Stimart. Thank you. Please go ahead. Tryn Stimart Good afternoon, and welcome to AbCellera’s first earnings conference call and our 2020 annual business update. We are pleased to have you
For further details see:
AbCellera Biologics' (ABCL) CEO Carl Hansen on Q4 2020 Results - Earnings Call Transcript